로딩 중…
지수 로딩 중…
Atea Pharmaceuticals, Inc.
AVIR· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$4.36+0.69%
2026-06-18
Price Chart
Atea Pharmaceuticals, Inc.+35.83%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $349M |
| Revenue | $0.00 |
| Net Income | $-170M |
| Total Assets | $267M |
| Net Assets | $234M |
| Value | |
| P/B | 1.49x |
| FCF Yield | -42.38% |
| Profitability | |
| ROE | -72.53% |
| ROA | -63.47% |
| Financial Health | |
| Debt Ratio | 14.28% |
| Total Debt | $634000.00 |
| FCF | $-148M |
| Cash | $79M |
| Current Ratio | 7.89x |
| Performance | |
| 1Y Return | 35.83% |
| 1M Return | 5.06% |
| From 52W High | -32.40% |
| 1Y MDD | -33.33% |
| Trading | |
| Volume | 378,220 shares |
| Trading Value | $2M |
| Per Share | |
| EPS | $-2.03 |
| BPS | $3.53 |